- Home
- NKLR vs AUTL Comparison
NKLR vs AUTL Comparison
Compare NKLR & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NKLR | AUTL |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | Italy | United Kingdom |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 500.6M | 431.2M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | NKLR | AUTL |
|---|---|---|
| Price | $5.49 | $1.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $15.00 | $8.50 |
| AVG Volume (30 Days) | 419.1K | ★ 1.7M |
| Earning Date | 04-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $10,120,000.00 |
| Revenue This Year | N/A | $84.74 |
| Revenue Next Year | N/A | $65.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 496.00 |
| 52 Week Low | $3.73 | $1.15 |
| 52 Week High | $12.43 | $2.70 |
Technical Indicators
Market Signals| Indicator | NKLR | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 66.18 | 54.72 |
| Support Level | $3.94 | $1.45 |
| Resistance Level | $5.73 | $1.52 |
| Average True Range (ATR) | 0.33 | 0.08 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 91.40 | 80.25 |
Price Performance
Historical ComparisonAbout NKLR Terra Innovatum Global N.V. Ordinary shares
Terra Innovatum Global NV is a micro modular nuclear solutions company that aims to deliver reliable, low-cost and zero-carbon power wherever energy demand is present through its first-of-a-kind reactor SOLO. SOLO is compact yet extremely powerful with one unit generating 1MWe of power, while designed with the strictest safety characteristics and the ability to run 24/7 without the need to refuel for 15 years. Its modular design aims to achieve maximum energy efficiency while significantly reducing the levelized cost of energy (LCOE). SOLO is built using off-the-shelf components and widely available fuel, low-enriched uranium (LEU), which de-risks its regulatory and commercial pathway.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.